Meanwhile, several important ICP genes, such as CD274, CTLA4, CD276, etc. were highly expressed in the PS1 and PS2 subtypes, indicating an immunosuppressive tumor microenvironment in these patients, and they were more likely to be benefit from ICIs. This evidence concerns the gene CD276 and neoplasm.